Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:803-806
Published online before print February 10, 2003, doi: 10.1161/01.CIR.0000057551.88851.09
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/6/803    most recent
01.CIR.0000057551.88851.09v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koshida, R.
Right arrow Articles by Pritchard, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koshida, R.
Right arrow Articles by Pritchard, K. A., Jr
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2003;107:803.)
© 2003 American Heart Association, Inc.


Brief Rapid Communications

Angiostatin

A Negative Regulator of Endothelial-Dependent Vasodilation

Ryoji Koshida, MD; Jingsong Ou, MD, PhD; Toshiro Matsunaga, MD; William M. Chilian, PhD; Keith T. Oldham, MD; Allan W. Ackerman, MS; Kirkwood A. Pritchard, Jr, PhD

From the Departments of Physiology (R.K., T.M., W.M.C.), Pediatric Surgery (J.O., K.T.O., A.W.A., K.A.P.), and Pharmacology & Toxicology (K.A.P.); Cardiovascular Center (R.K., J.O., T.M., W.M.C., K.T.O., K.A.P.); and Free Radical Research Center (K.A.P.), Medical College of Wisconsin, Milwaukee. Dr Chilian is now Chairman of Physiology at Louisiana State University.

Correspondence to Kirkwood A. Pritchard, Jr, PhD, Medical College of Wisconsin, 8701 Watertown Plank Rd, CVC M4060, Milwaukee, WI 53226 (E-mail kpritch{at}mcw.edu), or William M. Chilian, PhD, Professor and Head, Department of Physiology, Louisiana State University Health Science Center, 1901 Perido St, New Orleans, LA 70112 (E-mail chilian@LSUHSC.edu).

Background— Angiostatin is known to inhibit certain aspects of endothelial function, eg, angiogenesis. Here we investigated the effects of angiostatin on another aspect of endothelial function, vasodilation, and examined mechanisms of inhibition—namely, association of heat-shock protein 90 (hsp90) with endothelial nitric oxide synthase (eNOS) and endothelial generation of nitric oxide (·NO) and superoxide anion ({image}). This avenue of investigation was based on recent reports suggesting that hsp90 modulates NOS production of ·NO and {image}.

Methods and Results— Effects of angiostatin on vasodilation were determined in arterioles with the use of videomicroscopy in response to endothelium- and ·NO-dependent vasodilators, acetylcholine (ACh) and vascular endothelial growth factor (VEGF), and an endothelium-independent agonist, papaverine. Association of hsp90 with eNOS was determined in rat aortas and bovine aortic endothelial cells (BAECs). Effects of angiostatin on ·NO and {image} generation by BAECs were determined by ozone chemiluminescence and superoxide dismutase (SOD)–inhibitable ferricytochrome c reduction, respectively. Angiostatin impaired vasodilation mediated by ACh and VEGF but not papaverine. Pretreating arterioles with polyethylene glycolated–SOD (PEG-SOD) improved vasodilation to ACh and VEGF. Angiostatin decreased the association of hsp90 with eNOS in aortas and BAEC cultures and increased {image} generation in stimulated BAECs by an L{gamma}-nitroargininemethylester (L-NAME)–inhibitable mechanism.

Conclusions— These data indicate angiostatin alters endothelial function by allowing eNOS to generate {image} on activation. Such changes in enzyme function begin to explain, in part, why angiostatin is antiangiogenic and impairs endothelium-dependent vasodilation.


Key Words: angiostatin • nitric oxide synthase, endothelial • heat-shock protein 90 • nitric oxide • superoxides




This article has been cited by other articles:


Home page
BloodHome page
A. C. Frei, Y. Guo, D. W. Jones, K. A. Pritchard Jr, K. A. Fagan, N. Hogg, and N. J. Wandersee
Vascular dysfunction in a murine model of severe hemolysis
Blood, July 15, 2008; 112(2): 398 - 405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Weihrauch, H. Xu, Y. Shi, J. Wang, J. Brien, D. W. Jones, S. Kaul, R. A. Komorowski, M. E. Csuka, K. T. Oldham, et al.
Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1432 - H1441.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. W.Y. Chung, Y. N. Hsiang, L. A. Matzke, B. M. McManus, C. van Breemen, and E. B. Okon
Reduced Expression of Vascular Endothelial Growth Factor Paralleled With the Increased Angiostatin Expression Resulting From the Upregulated Activities of Matrix Metalloproteinase-2 and -9 in Human Type 2 Diabetic Arterial Vasculature
Circ. Res., July 21, 2006; 99(2): 140 - 148.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Boodhwani, Y. Nakai, S. Mieno, P. Voisine, C. Bianchi, E. G. Araujo, J. Feng, K. Michael, J. Li, and F. W. Sellke
Hypercholesterolemia Impairs the Myocardial Angiogenic Response in a Swine Model of Chronic Ischemia: Role of Endostatin and Oxidative Stress
Ann. Thorac. Surg., February 1, 2006; 81(2): 634 - 641.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Koshida, P. Rocic, S. Saito, T. Kiyooka, C. Zhang, and W. M. Chilian
Role of Focal Adhesion Kinase in Flow-Induced Dilation of Coronary Arterioles
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2548 - 2553.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Toyota, D. C. Warltier, T. Brock, E. Ritman, C. Kolz, P. O'Malley, P. Rocic, M. Focardi, and W. M. Chilian
Vascular Endothelial Growth Factor Is Required for Coronary Collateral Growth in the Rat
Circulation, October 4, 2005; 112(14): 2108 - 2113.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Aranda, J. C. Rivera, M. C. Jeziorski, J. Riesgo-Escovar, G. Nava, F. Lopez-Barrera, H. Quiroz-Mercado, P. Berger, G. Martinez de la Escalera, and C. Clapp
Prolactins Are Natural Inhibitors of Angiogenesis in the Retina
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2947 - 2953.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Y. Zhang, E. G. Teggatz, A.-P. Zou, W. B. Campbell, and P.-L. Li
Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2-{middle dot} production in the intact coronary endothelium
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H686 - H694.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Gonzalez, A. M. Corbacho, J. P. Eiserich, C. Garcia, F. Lopez-Barrera, V. Morales-Tlalpan, A. Barajas-Espinosa, M. Diaz-Munoz, R. Rubio, S.-H. Lin, et al.
16K-Prolactin Inhibits Activation of Endothelial Nitric Oxide Synthase, Intracellular Calcium Mobilization, and Endothelium-Dependent Vasorelaxation
Endocrinology, December 1, 2004; 145(12): 5714 - 5722.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Weihrauch, N. L. Lohr, B. Mraovic, L. M. Ludwig, W. M. Chilian, P. S. Pagel, D. C. Warltier, and J. R. Kersten
Chronic Hyperglycemia Attenuates Coronary Collateral Development and Impairs Proliferative Properties of Myocardial Interstitial Fluid by Production of Angiostatin
Circulation, May 18, 2004; 109(19): 2343 - 2348.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. A. Pritchard Jr., J. Ou, Z. Ou, Y. Shi, J. P. Franciosi, P. Signorino, S. Kaul, C. Ackland-Berglund, K. Witte, S. Holzhauer, et al.
Hypoxia-induced acute lung injury in murine models of sickle cell disease
Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L705 - L714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Ou, J. T. Fontana, Z. Ou, D. W. Jones, A. W. Ackerman, K. T. Oldham, J. Yu, W. C. Sessa, and K. A. Pritchard Jr.
Heat shock protein 90 and tyrosine kinase regulate eNOS NO{middle dot} generation but not NO{middle dot} bioactivity
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H561 - H569.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. B. Perchick and H. N. Jabbour
Cyclooxygenase-2 Overexpression Inhibits Cathepsin D-Mediated Cleavage of Plasminogen to the Potent Antiangiogenic Factor Angiostatin
Endocrinology, December 1, 2003; 144(12): 5322 - 5328.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Ou, Z. Ou, D. W. Jones, S. Holzhauer, O. A. Hatoum, A. W. Ackerman, D. W. Weihrauch, D. D. Gutterman, K. Guice, K. T. Oldham, et al.
L-4F, an Apolipoprotein A-1 Mimetic, Dramatically Improves Vasodilation in Hypercholesterolemia and Sickle Cell Disease
Circulation, May 13, 2003; 107(18): 2337 - 2341.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Ou, Z. Ou, D. G. McCarver, R. N. Hines, K. T. Oldham, A. W. Ackerman, and K. A. Pritchard Jr.
Trichloroethylene Decreases Heat Shock Protein 90 Interactions with Endothelial Nitric Oxide Synthase: Implications for Endothelial Cell Proliferation
Toxicol. Sci., May 1, 2003; 73(1): 90 - 97.
[Abstract] [Full Text] [PDF]